Boothbay Fund Management, LLC Ac Immune Sa Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $136,889 - $184,138	-22,079 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.04 - $8.37 $52,312 - $72,492	8,661 Added 64.55%	22,079 $175,000
Q1 2021 May 17, 2021	BUY	$5.32 - $8.96 $71,383 - $120,225	13,418 New	13,418 $102,000
Q3 2019 Nov 14, 2019	SELL	$4.8 - $5.89 $536,419 - $658,231	-111,754 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.72 - $5.88 $81,599 - $101,653	17,288 Added 18.3%	111,754 $620,000
Q1 2019 May 15, 2019	BUY	$3.65 - $11.68 $255,952 - $819,048	70,124 Added 288.08%	94,466 $477,000
Q4 2018 Feb 14, 2019	SELL	$7.35 - $11.7 $114,792 - $182,730	-15,618 Reduced 39.08%	24,342 $230,000
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $314,884 - $657,342	39,960 New	39,960 $320,000

28.6M

163K

37.6K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $303M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.